Willow Biosciences Stock Performance
| CANSF Stock | USD 0.02 0.01 28.57% |
The firm maintains a market beta of -1.05, which attests to a somewhat significant risk relative to the market. As the market becomes more bullish, returns on owning Willow Biosciences are expected to decrease slowly. On the other hand, during market turmoil, Willow Biosciences is expected to outperform it slightly. At this point, Willow Biosciences has a negative expected return of -0.21%. Please make sure to check out Willow Biosciences' treynor ratio, as well as the relationship between the kurtosis and day typical price , to decide if Willow Biosciences performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Willow Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
| Begin Period Cash Flow | 15.9 M | |
| Total Cashflows From Investing Activities | -1.7 M |
Willow |
Willow Biosciences Relative Risk vs. Return Landscape
If you would invest 4.36 in Willow Biosciences on December 22, 2024 and sell it today you would lose (2.36) from holding Willow Biosciences or give up 54.13% of portfolio value over 90 days. Willow Biosciences is currently producing negative expected returns and takes up 14.0771% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than Willow, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Willow Biosciences Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Willow Biosciences' investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Willow Biosciences, and traders can use it to determine the average amount a Willow Biosciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0153
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CANSF |
Estimated Market Risk
| 14.08 actual daily | 96 96% of assets are less volatile |
Expected Return
| -0.21 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Willow Biosciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Willow Biosciences by adding Willow Biosciences to a well-diversified portfolio.
Willow Biosciences Fundamentals Growth
Willow OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Willow Biosciences, and Willow Biosciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Willow OTC Stock performance.
| Return On Equity | -0.55 | |||
| Return On Asset | -0.4 | |||
| Operating Margin | (62.65) % | |||
| Current Valuation | (3.21 M) | |||
| Shares Outstanding | 123.72 M | |||
| Price To Earning | 4.15 X | |||
| Price To Book | 0.64 X | |||
| Price To Sales | 31.67 X | |||
| Revenue | 133 K | |||
| EBITDA | (2.92 M) | |||
| Cash And Equivalents | 23.04 M | |||
| Cash Per Share | 0.19 X | |||
| Total Debt | 607 K | |||
| Debt To Equity | 0.02 % | |||
| Book Value Per Share | 0.17 X | |||
| Cash Flow From Operations | (18.23 M) | |||
| Earnings Per Share | 0.02 X | |||
| Total Asset | 35.02 M | |||
About Willow Biosciences Performance
By analyzing Willow Biosciences' fundamental ratios, stakeholders can gain valuable insights into Willow Biosciences' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Willow Biosciences has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Willow Biosciences has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada. Willow Biosciences Inc. was incorporated in 1981 and is headquartered in Calgary, Canada. Willow Biosciences is traded on OTC Exchange in the United States.Things to note about Willow Biosciences performance evaluation
Checking the ongoing alerts about Willow Biosciences for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Willow Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Willow Biosciences generated a negative expected return over the last 90 days | |
| Willow Biosciences has high historical volatility and very poor performance | |
| Willow Biosciences has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 133 K. Net Loss for the year was (6.14 M) with profit before overhead, payroll, taxes, and interest of 111 K. | |
| Willow Biosciences has accumulated about 23.04 M in cash with (18.23 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.19, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 27.0% of the company shares are held by company insiders |
- Analyzing Willow Biosciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Willow Biosciences' stock is overvalued or undervalued compared to its peers.
- Examining Willow Biosciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Willow Biosciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Willow Biosciences' management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Willow Biosciences' otc stock. These opinions can provide insight into Willow Biosciences' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Willow OTC Stock analysis
When running Willow Biosciences' price analysis, check to measure Willow Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Willow Biosciences is operating at the current time. Most of Willow Biosciences' value examination focuses on studying past and present price action to predict the probability of Willow Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Willow Biosciences' price. Additionally, you may evaluate how the addition of Willow Biosciences to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |